Novel direct effects of SGLT2 inhibitor, Canagliflozin, on myocardial redox state in humans

Kondo H., Akoumianakis I., Akawi N., Cristina M., Herdman L., Badi I., Kotanidis C., Akbar N., Antonopoulos A., Oikonomou E., Chuaiphichai S., Channon K., Antoniades C.

Type

Conference paper

Publication Date

10/2019

Volume

40

Pages

3872 - 3872

Permalink